NasdaqCM - Nasdaq Real Time Price USD
Aytu BioPharma, Inc. (AYTU)
1.5800
+0.0900
+(6.04%)
As of 11:02:24 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 173.5k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Mar 31, 2025 |
| DISBROW JOSHUA R. Chief Executive Officer | Purchase at price 1.30 per share. | Direct | 19,500 | Feb 28, 2025 |
| SELHORN RYAN J Chief Financial Officer | -- | Direct | -- | Feb 5, 2025 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Dec 31, 2024 |
| SELHORN RYAN J Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 11, 2024 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| DOCKERY CARL C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Sep 30, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Jun 28, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 2.85 per share. | Indirect | 2,323,368 | Jun 14, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Mar 28, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Dec 29, 2023 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Sep 29, 2023 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2023 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| DOCKERY CARL C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Jun 30, 2023 |
| PYSZCZYMUKA GREG Officer | Purchase at price 1.87 per share. | Direct | 22,428 | Jun 16, 2023 |
| DISBROW JOSHUA R. Chief Executive Officer | Purchase at price 1.86 per share. | Direct | 26,079 | Jun 14, 2023 |
Related Tickers
GELS Gelteq Limited
1.7201
+0.58%
SXTC China SXT Pharmaceuticals, Inc.
1.7898
+33.57%
PRFX PainReform Ltd.
1.9900
+1.01%
IXHL Incannex Healthcare Inc.
0.1826
+2.01%
ELTP Elite Pharmaceuticals, Inc.
0.5700
+2.41%
BFRI Biofrontera Inc.
0.5951
-0.73%
PTPI Petros Pharmaceuticals, Inc.
0.0313
-1.96%
OGI Organigram Global Inc.
1.3450
+2.68%
ZYBT Zhengye Biotechnology Holding Limited
6.30
+0.16%
LFCR Lifecore Biomedical, Inc.
6.98
+3.41%